These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7003573)

  • 1. Papaverine and hepatotoxicity.
    Pathy MS; Reynolds AJ
    Postgrad Med J; 1980 Jul; 56(657):488-90. PubMed ID: 7003573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity of papaverine.
    Kiaer HW; Olsen S; Ronnov-Jessen V
    Arch Pathol; 1974 Nov; 98(5):292-6. PubMed ID: 4413667
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatotoxicity due to treatment with papaverine. Report of four cases.
    Ronnov-Jessen V; Tjernlund A
    N Engl J Med; 1969 Dec; 281(24):1333-5. PubMed ID: 5355438
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatotoxicity due to papaverine hydrochloride.
    Shah S
    N Engl J Med; 1970 May; 282(22):1271. PubMed ID: 5442643
    [No Abstract]   [Full Text] [Related]  

  • 5. Papaverine revisited as a hepatotoxin.
    Zimmerman HJ
    N Engl J Med; 1969 Dec; 281(24):1364-5. PubMed ID: 5355442
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical observations following papaverine therapy.
    Snider GB; Gogate SA
    Ohio State Med J; 1978 Sep; 74(9):571-3. PubMed ID: 704011
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined hepatotoxicity and neurotoxicity following sulphasalazine administration.
    Smith MD; Gibson GE; Rowland R
    Aust N Z J Med; 1982 Feb; 12(1):76-80. PubMed ID: 6123306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute liver damage after papaverine].
    Niklasson PM; Runehagen A
    Lakartidningen; 1982 Dec; 79(50):4767. PubMed ID: 7154789
    [No Abstract]   [Full Text] [Related]  

  • 9. Papaverine-induced chronic liver disease.
    Poncin E; Silvain C; Touchard G; Barbier J; Beauchant M
    Gastroenterology; 1986 Apr; 90(4):1051-3. PubMed ID: 3949106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis with rapid evolution to cirrhosis: role of papaverine].
    Jobard JM; Cleau D; Vuitton D; Wagschal G; Daoudal P; Prenat T
    Gastroenterol Clin Biol; 1990; 14(11):896-7. PubMed ID: 2276577
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic hepatitis after long-term administration of papaverine (author's transl)].
    Poupon R; Longchal C; Darnis F
    Gastroenterol Clin Biol; 1978 Mar; 2(3):305-8. PubMed ID: 648801
    [No Abstract]   [Full Text] [Related]  

  • 12. [Papaverine hepatitis].
    Chousterman M; Pulik M; Perie G
    Nouv Presse Med; 1980 Jun; 9(27):1899. PubMed ID: 7402895
    [No Abstract]   [Full Text] [Related]  

  • 13. [Papaverine and liver damage. Investigation of liver function in 25 patients treated with papaverine intra-arterially].
    Westheim A
    Tidsskr Nor Laegeforen; 1972 Oct; 92(30):2020-2. PubMed ID: 4634644
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic hepatitis as complication of cirrhosis, due to papaverine].
    Deséchalliers JP; Lerebours E; Tilly H; Colin R
    Gastroenterol Clin Biol; 1981; 5(8-9):818-9. PubMed ID: 7297820
    [No Abstract]   [Full Text] [Related]  

  • 15. The natural history of histologically proved drug induced liver disease.
    Aithal PG; Day CP
    Gut; 1999 May; 44(5):731-5. PubMed ID: 10205214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 17. Papaverine hydrochloride: the evaluation of two new dosage forms.
    Arnold JD; Baldridge J; Riley B; Brody G
    Int J Clin Pharmacol Biopharm; 1977 May; 15(5):230-3. PubMed ID: 326689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind study of papaverine hydrochloride on the efficacy in the treatment of intermittent claudication.
    Seino Y; Rose HB; Kanazawa M; Vyden JK; Wall FJ
    Angiology; 1983 Apr; 34(4):257-65. PubMed ID: 6340562
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained release papaverine in peripheral ischemia: report of 21 ambulatory cases with oscillometric studies.
    Tibbs EE
    South Med J; 1969 Jul; 62(7):875-8. PubMed ID: 5790687
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of controlled-release papaverine pellets in preventing symptomatic cerebral vasospasm.
    Dalbasti T; Karabiyikoglu M; Ozdamar N; Oktar N; Cagli S
    J Neurosurg; 2001 Jul; 95(1):44-50. PubMed ID: 11453397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.